{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:35:25Z","timestamp":1787070925721,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>There are very few prospective studies comparing simultaneous integrated boost versus sequential boost in the setting of definitive treatment modality of head and neck squamous cell cancer (HNSCC), especially in the Indian scenario.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>We prospectively randomized 50 patients with biopsy-proven squamous cell carcinoma of the oropharynx, hypopharynx, and larynx malignancies, stage T1\u20133, enlarged node measuring \u22643 cm that are planned for definitive radiotherapy with chemotherapy into either hypo-fractionated simultaneous integrated (Hypo-SIB VMAT) boost arm or conventional (Conv-VMAT) boost arm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Most of the patients were men and aged less than 50 years. Patients with nodal involvement were 76% in Hypo-SIB VMAT and 80% in Conv-VMAT arm. The overall stage group distribution of II, III, and IVA were 16%, 44%, 40%, and 12%, 56%, and 32%, respectively, in both arms. All patients completed the intended treatment in both arms. Overall survival at the end of 2 years was 84% in Hypo-SIB VMAT arm and 80% in the Conv-VMAT arm (P = 0.25); disease-free survival (DFS) was 88% and 72%, respectively (P = 0.12); and locoregional recurrence-free survival (LRFS) was 92% and 84%, respectively (P = 0.38). All the acute and chronic toxicities in both the arms were comparable with no significant difference in any of the toxicities. The average overall treatment time (OTT) in Hypo-SIB VMAT arm is 39.4 days and in Conv-VMAT arm is 50.2 days (P = 0.00001) which is statistically significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Accelerated Hypo-SIB VMAT has similar response and toxicities as compared to Conv-VMAT in the setting of definitive concurrent chemoradiation of HNSCC patients with the advantage of less OTT, faster treatment delivery, and patient compliance.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_1613_20","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T01:12:07Z","timestamp":1686618727000},"page":"283-288","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["An experience with simultaneous integrated boost-volumetric-modulated arc therapy in the definitive treatment of head and neck cancer: An Indian data"],"prefix":"10.4103","volume":"19","author":[{"given":"Rashmi","family":"Shivananjappa","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeet Kumar","family":"Mandal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Vishwanathan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S N","family":"Geeta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Vydehi Institute of Medical Sciences and Research Centre, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"R2-20241021","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0360-3016(94)00421-G","article-title":"Late effects of radiation therapy in the head and neck region","volume":"31","author":"Cooper","year":"1995","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1998","journal-title":"Acta Oncol"},{"key":"R5-20241021","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/j.0022-0337.2005.69.8.tb03989.x","article-title":"Cancer therapy-related oral mucositis","volume":"69","author":"Redding","year":"2005","journal-title":"J Dent Educ"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.rpor.2012.01.009","article-title":"A study on conventional IMRT and RapidArc treatment planning techniques for head and neck cancers","volume":"17","author":"Syam Kumar","year":"2012","journal-title":"Rep Pract Oncol Radiother"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1748-717X-8-26","article-title":"Multi-institutional comparison of volumetric modulated arc therapy vs. intensity-modulated radiation therapy for head and neck cancer: A planning study","volume":"8","author":"Holt","year":"2013","journal-title":"Radiat Oncol"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5306\/wjco.v3.i4.57","article-title":"Aprospective trial of volumetric Intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer","volume":"3","author":"Fung-Kee-Fung","year":"2012","journal-title":"World J Clin Oncol"},{"key":"R9-20241021","year":"2010","journal-title":"National Cancer Institute: National institutes of health, common terminology criteria for adverse events (CTCAE), Version 4.03"},{"key":"R10-20241021","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R11-20241021","first-page":"167","article-title":"IMRT with the use of simultaneous integrated boost in treatment of head and neck cancer: Acute toxicity evaluation","volume":"49","author":"Vo\u0161mik","year":"2006","journal-title":"ACTA Medica (Hradec Kr\u00e1lov\u00e9)"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.2014.55.3925","article-title":"Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for ead and neck carcinomas in the radiation therapy","volume":"32","author":"Nguyen-Tan","year":"2014","journal-title":"J Clin Oncol"},{"key":"R13-20241021","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.clon.2008.01.011","article-title":"Concomitant boost radiotherapy compared with conventional radiotherapy in squamous cell carcinoma of the head and neck-A phase III trial from a single institution in India","volume":"20","author":"Ghoshal","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.14740\/wjon1049w","article-title":"Evaluation of acute toxicity and early clinical outcome in head and neck cancers treated with conventional radiotherapy & simultaneous integrated boost arc radiotherapy","volume":"8","author":"Bahl","year":"2017","journal-title":"World J Oncol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13014-016-0756-x","article-title":"A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer","volume":"12","author":"Vlacich","year":"2017","journal-title":"Radiat Oncol"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/JCO.2016.34.15_suppl.6070","article-title":"Sequential boost versus integrated boost intensity modulated radiation therapy with concurrent chemotherapy for locally advanced head and neck cancer","volume":"34","author":"Cmelak","year":"2016","journal-title":"JCO"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"e94456","DOI":"10.1371\/journal.pone.0094456","article-title":"Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers","volume":"9","author":"Spiotto","year":"2014","journal-title":"PLoS One"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00066-011-2246-2","article-title":"Accelerated radiotherapy with concomitant boost technique (69.5 Gy\/5 weeks): An alternative in the treatment of locally advanced head and neck cancer","volume":"187","author":"Kubes","year":"2011","journal-title":"Strahlenther Onkol"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.steroids.2012.05.002","article-title":"Application of hypoiodite-mediated aminyl radical cyclization to synthesis of solasodine acetate","volume":"77","author":"Kou","year":"2012","journal-title":"Steroids"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"14067","DOI":"10.1021\/jacs.5b10172","article-title":"N7 methylation alters hydrogen-bonding patterns of guanine in duplex DNA","volume":"137","author":"Kou","year":"2015","journal-title":"J Am Chem Soc"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/14737140.2018.1446832","article-title":"An update on radiation therapy in head and neck cancers","volume":"18","author":"Mazzola","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"R22-20241021","first-page":"15975","article-title":"The dosimetric comparison of the radiotherapeutic plans between composite and synchronous planning approaches in sequential IMRT for nasopharyngeal carcinoma","volume":"8","author":"Zhou","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R23-20241021","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.meddos.2005.07.001","article-title":"Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer","volume":"30","author":"Chen","year":"2005","journal-title":"Med Dosim"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0360-3016(03)01569-4","article-title":"Assessment of different IMRT boost delivery methods on target coverage and normal-tissue sparing","volume":"57","author":"Dogan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jrr\/rrw010","article-title":"Preliminary analysis of the sequential integrated boost technique for intensity modulated radiotherapy for head and neck cancers","volume":"57","author":"Miyazaki","year":"2016","journal-title":"J Radiat Res"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/0360-3016(94)00475-Z","article-title":"Radiation dose-response of human tumors","volume":"32","author":"Okunieff","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R27-20241021","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0360-3016(89)90503-8","article-title":"Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation","volume":"16","author":"Maciejewski","year":"1989","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-20241021","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0360-3016(95)00228-Q","article-title":"Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions","volume":"33","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R29-20241021","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s13014-015-0472-y","article-title":"Arandomized phase II\/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma;preliminary result on acute adverse events","volume":"10","author":"Songthong","year":"2015","journal-title":"Radiat Oncol"},{"key":"R30-20241021","doi-asserted-by":"crossref","first-page":"e0124018","DOI":"10.1371\/journal.pone.0124018","article-title":"Arandomized pilot trial comparing position emission tomography (PET)-guided dose escalation radiotherapy to conventional radiotherapy in chemoradiotherapy treatment of locally advanced nasopharyngeal carcinoma","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"R31-20241021","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2147\/OTT.S99403","article-title":"Comparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"9","author":"Tao","year":"2016","journal-title":"Onco Targets Ther"},{"key":"R32-20241021","doi-asserted-by":"crossref","first-page":"e16942","DOI":"10.1097\/MD.0000000000016942","article-title":"A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine"},{"key":"R33-20241021","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00066-017-1251-5","article-title":"Arandomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma","volume":"194","author":"Lertbutsayanukul","year":"2018","journal-title":"Strahlenther Onkol"},{"key":"R34-20241021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.radonc.2013.03.002","article-title":"Adose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach","volume":"106","author":"Leclerc","year":"2013","journal-title":"Radiother Oncol"},{"key":"R35-20241021","doi-asserted-by":"crossref","first-page":"e16942","DOI":"10.1097\/MD.0000000000016942","article-title":"A comparison of clinical outcomes between simultaneous integrated boost (SIB) versus sequential boost (SEQ) intensity modulated radiation therapy (IMRT) for head and neck cancer: A meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R36-20241021","doi-asserted-by":"crossref","first-page":"20150764","DOI":"10.1259\/bjr.20150764","article-title":"Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head and neck cancer: Is there a place for critical swallowing structures dose sparing?","volume":"89","author":"Cilla","year":"2016","journal-title":"Br J Radiol"},{"key":"R37-20241021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13014-016-0711-x","article-title":"Reduced volume SIB\/IMRT\/IGRT to head and neck cancer in elderly and frail patients: Outcome and toxicity","volume":"11","author":"Straube","year":"2016","journal-title":"Radiat Oncol"},{"key":"R38-20241021","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13014-015-0535-0","article-title":"Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy","volume":"10","author":"Franzese","year":"2015","journal-title":"Radiat Oncol"},{"key":"R39-20241021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00066-015-0913-4","article-title":"Comparative treatment planning study on sequential vs simultaneous integrated boost in head and neck cancer patients \u2013 differences in dose distributions and potential implications of clinical practice","volume":"192","author":"Stromberger","year":"2016","journal-title":"Strahlenther Onkol"},{"key":"R40-20241021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ijrobp.2008.12.033","article-title":"Volumetric intensity modulated arc therapy vs conventional IMRT in head and neck cancer: A comparative planning and dosimetric study","volume":"74","author":"Verbakel","year":"2009","journal-title":"Int J radiat Oncol Biol Phys"},{"key":"R41-20241021","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity modulated radiation therapy for early stage oropharyngeal cancer (RTOG 00-22)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1613_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:39:00Z","timestamp":1787067540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.JCRT_1613_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1613_20","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"2020-11-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}